Evidence map›Paper›PMID 27613346›Full record

ReviewChild and adolescent psychiatric clinics of North America2016

The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

Christopher J Hammond

Abstract readReview
In one paragraph

Review in Child and adolescent psychiatric clinics of North America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Implementation of Substance Use Services to Justice-Involved Youth: Examining Barriers, Facilitators, and Best Practices.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Substance-induced Psychosis in Youth.Child and adolescent psychiatric clinics of North America · 2020
    Review
  9. Prescription Drug Misuse: Sources of Controlled Medications in Adolescents.Journal of the American Academy of Child and Adolescent Psychiatry · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Christopher J HammondBehavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Campus, 50 Nathan Shock Drive, Baltimore, MD 21224, USA. Electronic address: chammo20@jhmi.edu.
Behavioral Pharma (United States) · US

Funding

AACAP Physician Scientist Program in Substance UseK12DA000357 · NIDA · AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH · PI Kevin M. Gray · 1998 to 2026
$29.1M
NIDA NIH HHS K12 DA000357NIDA NIH HHS L40 DA032140
6 · The paper itself

Abstract

Adolescent substance use disorders (SUDs) are a significant public health issue due to the associated morbidity, mortality, and societal cost. While effective for some adolescents, psychosocial interventions generally produce small-to-moderate reductions in substance use. Most youth relapse within 12 months of treatment. One approach to improve outcomes is through adjunctive pharmacotherapy. Medication assisted treatments have been shown to improve adult SUD treatment outcomes, and preliminary studies in adolescents suggest that combining medication with psychosocial interventions may also enhance SUD outcomes for youth. This article presents a comprehensive review and grading of the evidence from studies conducted in adolescents with SUDs.

Indexed as

Randomized Controlled Trials as TopicAdolescentHumansSubstance-Related DisordersTreatment OutcomeAddictionAdolescenceDevelopmentMedicationPharmacotherapySubstance use disorder

Identifiers

PMID27613346
PMCPMC5018301
OpenAlexW2486855689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.